Systemic steroid use in children with allergic (IgE-mediated) asthma receiving omalizumab Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010
Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Aspirin-induced asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=239 Year: 2003
The effects of two weeks of repeated low-dose allergen exposure on sputum eosinophilic and neutrophilic inflammation in atopic asthma: protection by inhaled steroids? Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001
Small airways dysfunction: the link between allergic rhinitis and allergic asthma Source: Eur Respir J, 51 (2) 1701749; 10.1183/13993003.01749-2017 Year: 2018
Clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis Source: Annual Congress 2005 - PG18 - Inter-relationships between upper and lower airway diseases Year: 2005
Omalizumab therapy reduces oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma: European real-life experience Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Persistency of treatment response to omalizumab in patients with severe allergic (IgE-mediated) asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Hypersensitivity pneumonitis caused by oral aspirin Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009
Allergic inflammation of the upper and lower airways: a continuum of disease? Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=211 Year: 2003
Hypersensitivity pneumonitis caused by occupational exposure to phytase Source: Eur Respir J 2009; 33: 1507-1509 Year: 2009
Cough sensitivity changes in allergic rhinitis and atopic dermatitis without clinical symptoms from lower airways Source: Eur Respir J 2002; 20: Suppl. 38, 188s Year: 2002
Allergic rhinitis and asthma: combined syndrome, unified treatment Source: Eur Respir J 2003; 22: Suppl. 45, 134s Year: 2003
Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006
Effect of adding montelukast on asthma and rhinitis in asthma patients with concomitant allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 121s Year: 2006
Humoral markers of inflammation in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2004; 24: Suppl. 48, 595s Year: 2004
Pathophysiology of severe non-allergic asthma Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma Year: 2019
Chronic paranasal sinusitis exacerbates allergic inflammation in patients with asthma and contributes to refractoriness to treatment Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012
Effect of desloratadine on patients suffer from allergic rhinitis and bronchial hyperreactivity Source: Eur Respir J 2003; 22: Suppl. 45, 135s Year: 2003